Naloxone: Clinical Trials

3 trials for Naloxone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Unknown 1

Follow Naloxone: new trials by email Literature Review of Naloxone trials Research Report on Naloxone

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naloxone for Opioid Associated Out of Hospital Cardiac Arrest
Naloxone 2 MG, Saline 2ml - Heart Arrest, Out-Of-Hospital, Opioid Overdose
Phase 2Not yet recruitingUniversity of California, San Francisco982027-03-012026-09-11
Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder
Naloxone hydrochloride, Placebo - Pathological Gambling, Gambling Disorder
Phase 2UnknownFinnish Institute for Health and Welfare1262018-02-222019-07-16
Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray
Naloxone hydrochloride 20mg/ml - Gambling, Opioid
Phase 2CompletedFinnish Institute for Health and Welfare202017-02-142019-09-12

Narrower conditions

Gambling (2)  ·  Opiate Overdose (1)  ·  Out-of-Hospital Cardiac Arrest (1)

Broader conditions

Mental Disorders (3)  ·  Behavior (2)  ·  Disruptive, Impulse Control, and Conduct Disorders (2)  ·  Risk-Taking (2)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Drug Misuse (1)  ·  Drug Overdose (1)  ·  Heart Arrest (1)  ·  Heart Diseases (1)  ·  Narcotic-Related Disorders (1)  ·  Opioid-Related Disorders (1)  ·  Prescription Drug Misuse (1)  ·  Substance-Related Disorders (1)

Interventions

Naloxone (3)  ·  Sodium Chloride (1)

Sponsors

Finnish Institute for Health and Welfare (2)  ·  University of California, San Francisco (1)

Countries

Finland (2)  ·  United States (1)

Top investigators

Hannu Alho, Prof. (2)  ·  Ralph Wang, MD, MAS (1)

Results publications

PMID 36130734

NIH funding

2017 (1)